ReachRxResearch
Home
Research
Sign Up
Study limitation
Back to Research Hub
  1. Home
  2. Research Hub
  3. Study limitation

Anti-PLA2R Positivity Does Not Exclude Malignancy in Membranous Nephropathy: Lessons from the Course After Tumor Treatment

Study limitation reported by the research below: “The mechanism by which tumors may drive anti-PLA2R antibody production is not fully established, adding biological uncertainty to the clinical conclusions.”

Papers